Raju Raval, MDThe James Cancer Center
- Central Nervous System Diseases
- Radiation Oncology
- Urogenital Cancers
Make an Appointment
My practice focuses on radiation oncology with a specialization in treating patients with genitourinary cancers and primary central nervous system lymphoma, a disease that attacks the lymph tissue of the brain and spinal cord. In addition, I’m an assistant professor of radiation oncology at The Ohio State University Medical School.
I completed my doctorate in molecular oncology (graduate research in angiogenesis and tumor hypoxia) at the University of Oxford as a Rhodes Scholar, and later received my medical degree from the University of Pennsylvania School of Medicine.
As a researcher, my laboratory focus at the OSUCCC – James is translational cancer research using combinations of immunotherapy, immune modulation, targeted radiosensitization and radiation therapy. My work has been published in more than a dozen medical journals such as the Journal for ImmunoTherapy of Cancer, British Journal of Cancer and American Journal of Clinical Oncology.
Cancer is a terrible disease that impacts thousands of people every year. Each of us at The James is committed to working collaboratively to fight cancer and help our patients have longer, happier lives.
Education and Background
University of Pennsylvania School of Medicine
- American Board of Radiology (Subspecialty: Radiation Oncology)
- Department of Radiation Oncology
I see patients at
The James Cancer Hospital and Solove Research Institute
460 West 10th Avenue, Columbus, Ohio 43210
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Raval has reported no financial relationships with medical device, research and/or drug companies.